1832 Asset Management L.P. Has $23.41 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

1832 Asset Management L.P. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.9% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 72,878 shares of the company’s stock after selling 7,090 shares during the period. 1832 Asset Management L.P.’s holdings in HCA Healthcare were worth $23,414,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. CreativeOne Wealth LLC acquired a new stake in HCA Healthcare during the first quarter worth about $231,000. New Mexico Educational Retirement Board raised its position in HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock valued at $4,636,000 after purchasing an additional 3,200 shares in the last quarter. Sanders Capital LLC boosted its holdings in shares of HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after purchasing an additional 456,738 shares in the last quarter. KBC Group NV raised its holdings in shares of HCA Healthcare by 60.6% during the 4th quarter. KBC Group NV now owns 365,984 shares of the company’s stock worth $99,065,000 after buying an additional 138,146 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC acquired a new stake in HCA Healthcare in the first quarter valued at about $566,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $405.71 on Tuesday. The company has a market cap of $106.26 billion, a P/E ratio of 20.22, a PEG ratio of 1.46 and a beta of 1.67. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The business has a 50-day moving average price of $372.34 and a two-hundred day moving average price of $341.21. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $409.42.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. During the same period in the prior year, the business earned $4.29 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. As a group, analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s payout ratio is 13.16%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Oppenheimer raised their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Robert W. Baird began coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price on the stock. Barclays raised their price objective on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. Morgan Stanley began coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Finally, Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,202 shares of company stock valued at $6,407,273. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.